Статті в журналах з теми "Immunosuppressive agents Mechanism of action"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Immunosuppressive agents Mechanism of action".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
McDevitt, Lisa M. "Immunosuppressive Agents on the Horizon." Journal of Pharmacy Practice 16, no. 6 (December 2003): 434–41. http://dx.doi.org/10.1177/0897190003259384.
Grbovic, Leposava, and Miroslav Radenkovic. "Therapeutic use of glucocorticoids and immunosuppressive agents." Srpski arhiv za celokupno lekarstvo 133, Suppl. 1 (2005): 67–73. http://dx.doi.org/10.2298/sarh05s1067g.
Robak, Tadeusz, Ewa Lech-Maranda, Anna Korycka, and Ewa Robak. "Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity." Current Medicinal Chemistry 13, no. 26 (November 1, 2006): 3165–89. http://dx.doi.org/10.2174/092986706778742918.
Valdoleiros, Sofia R., Isabel Furtado, Carolina Silva, Inês Correia Gonçalves, André Santos Silva, Olga Vasconcelos, Ana Aboim Horta, et al. "Protocolo de Prevenção e Tratamento de Infeções Associadas à Terapêutica Imunossupressora de Doenças Autoimunes." Acta Médica Portuguesa 34, no. 6 (June 1, 2021): 469. http://dx.doi.org/10.20344/amp.15625.
Bauer, Andrea C., Rodrigo F. Franco, and Roberto C. Manfro. "Immunosuppression in Kidney Transplantation: State of the Art and Current Protocols." Current Pharmaceutical Design 26, no. 28 (August 31, 2020): 3440–50. http://dx.doi.org/10.2174/1381612826666200521142448.
Gorantla, Vijay S., John H. Barker, Jon W. Jones, Kaustubha Prabhune, Claudio Maldonado, and Darla K. Granger. "Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies." Microsurgery 20, no. 8 (2000): 420–29. http://dx.doi.org/10.1002/1098-2752(2000)20:8<420::aid-micr13>3.0.co;2-o.
Taylor, Anna L., Christopher J. E. Watson, and J. Andrew Bradley. "Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy." Critical Reviews in Oncology/Hematology 56, no. 1 (October 2005): 23–46. http://dx.doi.org/10.1016/j.critrevonc.2005.03.012.
Stepkowski, Stanislaw M. "Molecular targets for existing and novel immunosuppressive drugs." Expert Reviews in Molecular Medicine 2, no. 4 (June 21, 2000): 1–23. http://dx.doi.org/10.1017/s1462399400001769.
Tan, Marcus, Thurston Heng, and Anselm Mak. "The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus." Cells 8, no. 4 (April 6, 2019): 323. http://dx.doi.org/10.3390/cells8040323.
Nelson, R. D., N. Shibata, R. P. Podzorski, and M. J. Herron. "Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action." Clinical Microbiology Reviews 4, no. 1 (January 1991): 1–19. http://dx.doi.org/10.1128/cmr.4.1.1.
Lu, C. Y., S. C. Sicher, and M. A. Vazquez. "Prevention and treatment of renal allograft rejection: new therapeutic approaches and new insights into established therapies." Journal of the American Society of Nephrology 4, no. 6 (December 1993): 1239–56. http://dx.doi.org/10.1681/asn.v461239.
Allard, David, Bertrand Allard, and John Stagg. "On the mechanism of anti-CD39 immune checkpoint therapy." Journal for ImmunoTherapy of Cancer 8, no. 1 (February 2020): e000186. http://dx.doi.org/10.1136/jitc-2019-000186.
MONAGHAN, PAUL, DARREN B. LENEGHAN, WESLEY SHAW, and ANGUS BELL. "The antimalarial action of FK506 and rapamycin: evidence for a direct effect on FK506-binding protein PfFKBP35." Parasitology 144, no. 7 (March 9, 2017): 869–76. http://dx.doi.org/10.1017/s0031182017000245.
Shanahan, Fergus, Gerald C. O'’Sullivan, and J. Kevin Collins. "Immunosppressive Agents in Inflammatory Bowel Disease: Current Status and Future Prospects." Canadian Journal of Gastroenterology 8, no. 6 (1994): 383–87. http://dx.doi.org/10.1155/1994/580410.
GROSU-BULARDA, Andreea, Oana VERMEŞAN, Luana LĂZĂRESCU, and Ioan LASCĂR. "Immunosuppression in transplant of vascularized composite allografts." Romanian Journal of Medical Practice 11, no. 2 (June 30, 2016): 160–71. http://dx.doi.org/10.37897/rjmp.2016.2.11.
Klintmalm, Goran B., and Björn Nashan. "The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence." Journal of Transplantation 2014 (2014): 1–45. http://dx.doi.org/10.1155/2014/845438.
Yang, Fan, Yang Li, Qian Zhang, Liang Tan, Longkai Peng, and Yong Zhao. "The Effect of Immunosuppressive Drugs on MDSCs in Transplantation." Journal of Immunology Research 2018 (July 3, 2018): 1–16. http://dx.doi.org/10.1155/2018/5414808.
Ingawale, Deepa K., Satish K. Mandlik, and Snehal S. Patel. "An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance." Journal of Complementary and Integrative Medicine 12, no. 1 (January 1, 2015): 1–13. http://dx.doi.org/10.1515/jcim-2014-0051.
Holt, Curtis D., Gordon Ingle, and Theodore M. Sievers. "Inhibitors of Calcineurin." Journal of Pharmacy Practice 16, no. 6 (December 2003): 414–33. http://dx.doi.org/10.1177/0897190003260317.
Muraille, Eric, Fabienne Andris, Bernard Pajak, K. Martin Wissing, Thibaut De Smedt, Fabrice Desalle, Michel Goldman, et al. "Downregulation of Antigen-Presenting Cell Functions After Administration of Mitogenic Anti-CD3 Monoclonal Antibodies in Mice." Blood 94, no. 12 (December 15, 1999): 4347–57. http://dx.doi.org/10.1182/blood.v94.12.4347.
Muraille, Eric, Fabienne Andris, Bernard Pajak, K. Martin Wissing, Thibaut De Smedt, Fabrice Desalle, Michel Goldman, et al. "Downregulation of Antigen-Presenting Cell Functions After Administration of Mitogenic Anti-CD3 Monoclonal Antibodies in Mice." Blood 94, no. 12 (December 15, 1999): 4347–57. http://dx.doi.org/10.1182/blood.v94.12.4347.424k31_4347_4357.
Löwenberg, Mark, Jurriaan Tuynman, Meike Scheffer, Auke Verhaar, Louis Vermeulen, Sander van Deventer, Daniel Hommes, and Maikel Peppelenbosch. "Kinome Analysis Reveals Nongenomic Glucocorticoid Receptor-Dependent Inhibition of Insulin Signaling." Endocrinology 147, no. 7 (July 1, 2006): 3555–62. http://dx.doi.org/10.1210/en.2005-1602.
Shustov, E. B., A. E. Kim, and M. B. Ivanov. "Molecular targets of immunotoxic action of drugs." Toxicological Review, no. 2 (May 15, 2020): 11–17. http://dx.doi.org/10.36946/0869-7922-2020-2-10-16.
Colby, Christine, Cheryl A. Stoukides, and Thomas R. Spitzer. "Antithymocyte Immunoglobulin in Severe Aplastic Anemia and Bone Marrow Transplantation." Annals of Pharmacotherapy 30, no. 10 (October 1996): 1164–74. http://dx.doi.org/10.1177/106002809603001016.
Blaess, Julien, Julia Walther, Arthur Petitdemange, Jacques-Eric Gottenberg, Jean Sibilia, Laurent Arnaud, and Renaud Felten. "Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage." Therapeutic Advances in Musculoskeletal Disease 12 (January 2020): 1759720X2095997. http://dx.doi.org/10.1177/1759720x20959971.
Fernández-Villa, Aguilar, and Rojo. "Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications." International Journal of Molecular Sciences 20, no. 20 (October 9, 2019): 4996. http://dx.doi.org/10.3390/ijms20204996.
Suuring, Maaike, and Aurélie Moreau. "Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies." International Journal of Molecular Sciences 22, no. 15 (July 26, 2021): 7970. http://dx.doi.org/10.3390/ijms22157970.
Kildyushevsky, A. V., Ya G. Moysyuk, A. V. Molochkov, T. A. Mitina, and A. P. Faenko. "Extracorporeal photopheresis in solid organ transplantation." Almanac of Clinical Medicine 48, no. 3 (October 5, 2020): 207–24. http://dx.doi.org/10.18786/2072-0505-2020-48-046.
Routy, B., T. Huynh, R. Fraser, and C. Séguin. "Vascular Endothelial Cell Function in Catastrophic Antiphospholipid Syndrome: A Case Report and Review of the Literature." Case Reports in Hematology 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/710365.
Bai, Fanqi, JianXiang Zou, Jun Yang, Edna Ku, Sheng Wei, Thomas P. Loughran, and P. K. Epling-Burnette. "Complex Immunosuppressive Action of Farnesyltransferase Inhibitor (FTI) R115777 (Tipifarnib, Zarnestra®) with Induction of Apoptosis in T Cells from Patients with Large Granular Lymphocyte (LGL) Leukemia." Blood 108, no. 11 (November 16, 2006): 4960. http://dx.doi.org/10.1182/blood.v108.11.4960.4960.
Wolf, Andrew, and Enrique Alvarez. "COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy." Neurology: Clinical Practice 11, no. 4 (April 14, 2021): 358–61. http://dx.doi.org/10.1212/cpj.0000000000001088.
Marciani, Dante J. "Sole Anti-inflammatory Immunomodulators: Innovative Drugs to Prevent and Treat Autoimmune Diseases and Proteopathies." Current Chinese Science 1, no. 2 (April 19, 2021): 273–85. http://dx.doi.org/10.2174/2210298101666210108110556.
Cuker, Adam, and Cindy E. Neunert. "How I treat refractory immune thrombocytopenia." Blood 128, no. 12 (September 22, 2016): 1547–54. http://dx.doi.org/10.1182/blood-2016-03-603365.
Alberti, C., M. Mediago, G. Chiapello, D. Bernardi, and G. Arena. "Retroperitoneal Fibrosis, Today: An Updating of Knowledges on this Subjet." Urologia Journal 73, no. 2 (April 2006): 205–16. http://dx.doi.org/10.1177/039156030607300201.
Andronova, V. L. "MODERN ETHIOTROPIC CHEMOTHERAPY OF HUMAN CYTOMEGALOVIRUS INFECTION: CLINICAL EFFECTIVENESS, MOLECULAR MECHANISM OF ACTION, DRUG RESISTANCE, NEW TRENDS AND PROSPECTS. PART 1." Problems of Virology, Russian journal 63, no. 5 (October 20, 2018): 202–11. http://dx.doi.org/10.18821/0507-4088-2018-63-5-202-211.
Karateev, D. E., and E. L. Luchikhina. "Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19)." Almanac of Clinical Medicine 48 (September 19, 2020): 51–67. http://dx.doi.org/10.18786/2072-0505-2020-48-036.
Pritulo, O. A., A. A. Petrov, and A. V. Petrov. "Evolution of immunotherapy methods for psoriasis and psoriatic arthritis: from total immunosuppression to selective treatment of therapeutic targets." Medical alphabet, no. 15 (2020) (September 12, 2020): 15–21. http://dx.doi.org/10.33667/2078-5631-2020-15-15-21.
Gediz, Fusun, and Senol Kobak. "Immune Checkpoint Inhibitors-related Rheumatic Diseases: What Rheumatologist Should Know?" Current Rheumatology Reviews 15, no. 3 (July 31, 2019): 201–8. http://dx.doi.org/10.2174/1573397115666190119094736.
Skolarczyk, Justyna, Joanna Pekar, and Barbara Nieradko-Iwanicka. "Immune disorders induced by exposure to pyrethroid insecticides." Postępy Higieny i Medycyny Doświadczalnej 71, no. 1 (June 8, 2017): 0. http://dx.doi.org/10.5604/01.3001.0010.3827.
Zang, Yimei. "Pharmacological Activities of Coumarin Compounds in Licorice: A Review." Natural Product Communications 15, no. 9 (September 2020): 1934578X2095395. http://dx.doi.org/10.1177/1934578x20953954.
Johnson, Theodore S., Catherine E. Terrell, and Michael B. Jordan. "Defining the Mechanism of Etoposide Activity in Hemophagocytic Lymphohistiocytosis Using a Murine Disease Model." Blood 114, no. 22 (November 20, 2009): 714. http://dx.doi.org/10.1182/blood.v114.22.714.714.
Wangchuk, Phurpa, Simon Apte, Michael Smout, Penny Groves, Alex Loukas, and Denise Doolan. "Defined Small Molecules Produced by Himalayan Medicinal Plants Display Immunomodulatory Properties." International Journal of Molecular Sciences 19, no. 11 (November 6, 2018): 3490. http://dx.doi.org/10.3390/ijms19113490.
Silva, Marcos V., Juliana R. Machado, Laura P. Rocha, Lúcio R. Castellano, Marlene A. Reis, and Rosana R. M. Corrêa. "CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”." Journal of Transplantation 2012 (2012): 1–14. http://dx.doi.org/10.1155/2012/203780.
Blaess, J., J. Walther, J. E. Gottenberg, J. Sibilia, L. Arnaud, and R. Felten. "AB0332 IMMUNOSUPPRESSIVE AND IMMONOMODULATING AGENTS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF CLINICAL TRIALS AND THEIR CURRENT DEVELOPMENT STAGE." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1464.1–1465. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1124.
Khanna, Reena, Mahmoud H. Mosli, and Brian G. Feagan. "Anti-Integrins in Ulcerative Colitis and Crohn's Disease: What Is Their Place?" Digestive Diseases 34, no. 1-2 (2016): 153–59. http://dx.doi.org/10.1159/000443132.
Smith, Melody M., William Powers, Cindy R. Giver, Ned Waller, and Christopher Flowers. "Mechanism for the Immuno-Suppresion Activity of Pentostatin: Selective Apoptosis of Naive T Cell Subsets." Blood 108, no. 11 (November 16, 2006): 5160. http://dx.doi.org/10.1182/blood.v108.11.5160.5160.
Ushkalova, E. A., S. K. Zyryanov, and K. E. Zatolochina. "Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide." Terapevticheskii arkhiv 91, no. 12 (December 15, 2019): 122–27. http://dx.doi.org/10.26442/00403660.2019.12.000471.
Dunđerski, Jadranka, and Gordana Matić. "Glucocorticoid Receptor in Health and Disease." Journal of Medical Biochemistry 28, no. 4 (October 1, 2009): 248–61. http://dx.doi.org/10.2478/v10011-009-0022-y.
Kelly, William James, Amber Jin Giles, and Mark Gilbert. "T lymphocyte-targeted immune checkpoint modulation in glioma." Journal for ImmunoTherapy of Cancer 8, no. 1 (February 2020): e000379. http://dx.doi.org/10.1136/jitc-2019-000379.
Dmitriev, S. E., D. O. Vladimirov, and K. A. Lashkevich. "A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis." Biochemistry (Moscow) 85, no. 11 (November 2020): 1389–421. http://dx.doi.org/10.1134/s0006297920110097.